Omvoh 300 mg, solution à diluer pour perfusion

7680689500010 CH-68950 Lösung
Omvoh 300 mg, solution à diluer pour perfusion
Fiches Amavita / Sun Store / Coop Vitality

Article details

Package size
1
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Lösung
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
05/05/2026
Summary of Product Characteristics
Français
05/05/2026
Summary of Product Characteristics
Italien
05/05/2026

Detailed composition

Substance Quantity Type Category
mirikizumabum
300.0 MG Substance Wirkstoff (Principe actif)
histidinum
- Substance HNIDK
histidini hydrochloridum monohydricum
- Substance HNIDK
natrii citras dihydricus
- Substance HNIDK
acidum citricum
- Substance HNIDK
natrii chloridum
- Substance HNIDK
mannitolum
- Substance HNIDK
polysorbatum 80
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK
natrium
17.969 MG Substance HBESI

Reimbursement information

Public price
CHF 1241.25
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/08/2024

Authorization holder

Eli Lilly (Suisse) SA

1214 Vernier

Authorization information

Swissmedic authorization number
68950
Drug name
Omvoh, solution à diluer pour perfusion
Galenic form
KOINF
ATC Code
L04AC24
Authorization status
Z
Dispensing category
B
First authorization
30/11/2023
Authorization expiration date
29/11/2028
IT Number
07.15.0.
Domain
Human medicine

Package details

Description (FR)
OMVOH conc perf 300 mg/15ml flac 15 ml
Description (DE)
OMVOH Inf Konz 300 mg/15ml Durchstf 15 ml
Market launch
30/11/2023
Narcotic (BTM)
No
Buy us a coffee Explore the data